142 related articles for article (PubMed ID: 3898352)
1. In vivo treatment of rats with monoclonal anti-T-cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis.
Holmdahl R; Olsson T; Moran T; Klareskog L
Scand J Immunol; 1985 Aug; 22(2):157-69. PubMed ID: 3898352
[TBL] [Abstract][Full Text] [Related]
2. Modulation of experimental allergic neuritis in rats by in vivo treatment with monoclonal anti T cell antibodies.
Strigård K; Olsson T; Larsson P; Holmdahl R; Klareskog L
J Neurol Sci; 1988 Feb; 83(2-3):283-91. PubMed ID: 3258628
[TBL] [Abstract][Full Text] [Related]
3. Modulation of experimental allergic encephalomyelitis in Lewis rats by monoclonal anti-T cell antibodies.
Brinkman CJ; Ter Laak HJ; Hommes OR
J Neuroimmunol; 1985 Jan; 7(4):231-8. PubMed ID: 3155525
[TBL] [Abstract][Full Text] [Related]
4. T cell subsets and Ia-positive cells in the sciatic nerve during the course of experimental allergic neuritis.
Ota K; Irie H; Takahashi K
J Neuroimmunol; 1987 Jan; 13(3):283-92. PubMed ID: 3540006
[TBL] [Abstract][Full Text] [Related]
5. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease.
Linington C; Mann A; Izumo S; Uyemura K; Suzuki M; Meyermann R; Wekerle H
J Immunol; 1986 Dec; 137(12):3826-31. PubMed ID: 2431045
[TBL] [Abstract][Full Text] [Related]
6. Major histocompatibility antigens and lymphocyte subsets during experimental allergic neuritis in the Lewis rat.
Hughes RA; Atkinson PF; Gray IA; Taylor WA
J Neurol; 1987 Aug; 234(6):390-5. PubMed ID: 3498802
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of Ia-expressing cells and T lymphocytes of different subsets during experimental allergic neuritis in Lewis rats.
Olsson T; Holmdahl R; Klareskog L; Forsum U; Kristensson K
J Neurol Sci; 1984; 66(2-3):141-9. PubMed ID: 6241627
[TBL] [Abstract][Full Text] [Related]
8. Elimination of CD8+ T cells in vivo does not break induced immunospecific tolerance to experimental allergic neuritis in rats.
Strigård K; Olsson T; Larsson P; Holmdahl R; Höjeberg B; Klareskog L
Scand J Immunol; 1988 Sep; 28(3):325-30. PubMed ID: 2461582
[TBL] [Abstract][Full Text] [Related]
9. In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats.
Larsson P; Holmdahl R; Dencker L; Klareskog L
Immunology; 1985 Nov; 56(3):383-91. PubMed ID: 2934315
[TBL] [Abstract][Full Text] [Related]
10. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
Zhu J; Zou LP; Bakhiet M; Mix E
J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to P2 and P1 myelin antigens in experimental allergic neuritis and allergic encephalomyelitis.
Zweiman B; Moskovitz AR; Rostami A; Lisak RP; Pleasure DE; Brown MJ
J Neuroimmunol; 1982 Jun; 2(3-4):331-6. PubMed ID: 6177713
[TBL] [Abstract][Full Text] [Related]
12. Suppression of experimental autoimmune neuritis by leflunomide.
Korn T; Toyka K; Hartung HP; Jung S
Brain; 2001 Sep; 124(Pt 9):1791-802. PubMed ID: 11522581
[TBL] [Abstract][Full Text] [Related]
13. In vivo monoclonal antibody treatment with Ox19 (anti-rat CD5) causes disease relapse and terminates P2-induced immunospecific tolerance in experimental allergic neuritis.
Strigård K; Larsson P; Holmdahl R; Klareskog L; Olsson T
J Neuroimmunol; 1989 Jun; 23(1):11-8. PubMed ID: 2470777
[TBL] [Abstract][Full Text] [Related]
14. Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies.
Schmidt J; Elflein K; Stienekemeier M; Rodriguez-Palmero M; Schneider C; Toyka KV; Gold R; Hünig T
J Neuroimmunol; 2003 Jul; 140(1-2):143-52. PubMed ID: 12864982
[TBL] [Abstract][Full Text] [Related]
15. Changes in lymphocyte subsets during the course of experimental allergic neuritis.
Brosnan JV; Fellowes R; Craggs RI; King RH; Bowley TJ; Thomas PK
Brain; 1985 Jun; 108 ( Pt 2)():315-34. PubMed ID: 3891010
[TBL] [Abstract][Full Text] [Related]
16. Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes.
Hodgkinson SJ; Westland KW; Pollard JD
J Neurol Sci; 1994 May; 123(1-2):162-72. PubMed ID: 8064309
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive effect of FK506 on experimental allergic neuritis in Lewis rats: change of T cell subsets.
Adachi A; Araga S; Takahashi K
Intern Med; 1992 Jan; 31(1):6-10. PubMed ID: 1373661
[TBL] [Abstract][Full Text] [Related]
18. Effect of experimental allergic neuritis serum on normal rat peripheral nerve.
Rosen JL; Brown MJ; Rostami A
Pathobiology; 1990; 58(2):95-8. PubMed ID: 1694436
[TBL] [Abstract][Full Text] [Related]
19. Ia-expressing cells and T lymphocytes of different subsets in peripheral nerve tissue during experimental allergic neuritis in Lewis rats.
Olsson T; Holmdahl R; Klareskog L; Forsum U
Scand J Immunol; 1983 Oct; 18(4):339-43. PubMed ID: 6606220
[TBL] [Abstract][Full Text] [Related]
20. Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats.
Zhu J; Link H; Mix E; Olsson T; Huang WX
Acta Neurol Scand; 1994 Jul; 90(1):19-25. PubMed ID: 7524259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
